Back to search
NL

NL · NL · NL-abc1aada9046

Briumvi 150 mg concentraat voor oplossing voor infusie

ATC L04AG14

Last synced from CBG-MEB (Netherlands) on

Identification

ManufacturerNeuraxpharm Pharmaceuticals S.L.
CountryNL (NL)
ATC codeL04AG14
Dispensing
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026

Packs · 1

  • cbg_meb_id
    EU/1/23/1730

Annotations

No annotations yet.

Raw payload (JSON)
{
  "form": "Concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/briumvi-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Ublituximab",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129295",
  "excipients": [
    "NATRIUMCHLORIDE",
    "POLYSORBAAT 80 (E 433)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "UBLITUXIMAB"
  ],
  "leaflet_url": null,
  "authorised_at": "2023/05/31",
  "procedure_number": "EMEA/H/C/005914",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/23/1730",
  "additional_monitoring": "Y"
}

Related drugs

Other records sharing ATC code L04AG14.

Access this data programmatically

Query Briumvi 150 mg concentraat voor oplossing voor infusie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.